We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00629876
Recruitment Status : Terminated (Due to the uncertain regulatory landscape for erythropoiesis-stimulating agents in oncology indications.)
First Posted : March 6, 2008
Last Update Posted : December 1, 2011
Sponsor:
Collaborator:
Affymax
Information provided by (Responsible Party):
Takeda

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2008
  Study Completion Date : June 2008